Catalyst Wire Dossier Catalyst Wire Dossier

Incretin-based therapy (unspecified)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Incretin-based therapy (unspecified), covering 2016-08-29 to 2016-08-29. Get the full timeline:

Most recent: Clinical Trial Update: Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based Therapy [Phase 2, Phase 3]

See pricing